Writtle University College and ARU have merged. Writtle’s full range of college, degree, postgraduate and short courses will still be delivered on the Writtle campus. See our guide to finding Writtle information on this site.

Dr Hussein Al-Ali


Medical Technology Research Centre

Faculty of Science and Engineering
Life Sciences
Areas of Expertise:
Cancer biology

Hussein joined ARU in November 2018 as a Research Fellow. Hussein’s research focuses on assessing the efficacy of anticancer treatment in several cancer types including breast, lung, colorectal, ovarian and pancreatic cancers. Hussein is now a Lecturer and Deputy Course Leader for MSc Applied Bioscience. He is a member of the Biomedical Research Group.

[email protected]


Prior to working at ARU, Hussein held the position of a research fellow at Brunel University London and had investigated how defects in DNA repair contribute to controlling the response to anticancer therapy. Hussein also utilised imaging flow cytometry to identify and enumerate circulating tumour cells in patients’ blood.

Hussein is now a lecturer in Biomedical Science and the deputy course leader in MSc Applied Bioscience at ARU. His research now revolves around evaluating the efficacy of novel antibodies in treating a variety of cancers and identifying the mechanism of cell kill in collaboration with commercial investors.

Spoken Languages
  • Arabic
  • English
Research interests
  • Cancer Diagnosis
  • Novel Cancer Therapy
  • Proteomic Analysis
  • Imaging Flow Cytometry

Module Leader for Undergraduate Project

Module Leader for Molecular Genetics and Bioinformatics

Module Leader for Contemporary Medical Diagnostics

Deputy Course Leader for MSc Applied Bioscience

  • BSc Biomedical Sciences, Brunel University London (2012)
  • PhD, Brunel University London (2017)
Memberships, editorial boards
  • Member, Royal Society of Biology Associate
  • Associate Fellow, Higher Education Academy
Selected recent publications

Bourton, E. C., Ahorner, P. A., Plowman, P. N., Zahir, S. A., Al-Ali, H., Parris, C. N., 2017. The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/- lymphoblastoid cells. Journal of Cancer, 23(19), pp. 4048-4056.

Parris, C. N., Adam-Zahir, S., Al-Ali, H., Bourton, E. C., Plowman, C., Plowman, P. N., 2015. Enhanced γ-H2AX DNA damage foci detection using multi-magnification and extended depth of field in imaging flow cytometry. Journal of Cytometry, Part A, 87(8), pp. 717-23.